Position in URGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,077,499
-$767,656 QoQ
Shares Held
115,545
-4.9% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARK Investment Management LLC holds $1,307,636,479 across 17 Biotechnology names. URGN ranks #15 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,313,623 | $538,189,046 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
12,133,433 | $289,139,708 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
14,509,247 | $186,008,546 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
40,212,769 | $123,453,200 | |
| 5 | ABSI |
Absci Corp
|
13,726,169 | $41,178,507 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
|
1,721,135 | $26,677,592 | |
| 7 | PRME |
Prime Medicine, Inc.
|
6,246,827 | $21,738,957 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
288,716 | $21,679,684 |
All Filings in URGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,077,499 | 115,545 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,845,155 | 121,484 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,528,064 | 126,720 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,275,487 | 166,094 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,054,837 | 185,790 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,492,576 | 140,148 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,544,751 | 121,634 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,546,885 | 151,781 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,194,935 | 146,329 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,422,875 | 161,525 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $3,015,960 | 215,272 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,089,851 | 201,918 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $2,501,693 | 270,746 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,746,840 | 196,938 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,343,752 | 281,701 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,474,395 | 302,124 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $2,904,541 | 333,472 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,773,548 | 186,493 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $4,106,855 | 244,165 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,829,106 | 316,248 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $5,685,627 | 291,870 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,329,317 | 73,769 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $659,949 | 34,212 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,233,072 | 47,208 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $300,086 | 16,821 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||